Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malignant Hyperthermia | 5 | 2023 | 15 | 1.900 |
Why?
|
| Muscle, Skeletal | 11 | 2025 | 333 | 1.900 |
Why?
|
| Calcium | 11 | 2023 | 356 | 1.860 |
Why?
|
| Halothane | 3 | 2023 | 10 | 0.840 |
Why?
|
| Caffeine | 3 | 2023 | 53 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 148 | 0.790 |
Why?
|
| Muscle Contraction | 2 | 2023 | 67 | 0.770 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2023 | 39 | 0.630 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2022 | 157 | 0.580 |
Why?
|
| Calcium Signaling | 5 | 2022 | 110 | 0.540 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 34 | 0.500 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 5 | 2023 | 134 | 0.480 |
Why?
|
| Animals | 14 | 2025 | 3293 | 0.480 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 56 | 0.390 |
Why?
|
| Calsequestrin | 6 | 2017 | 30 | 0.390 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 88 | 0.370 |
Why?
|
| Hyperglycemia | 2 | 2023 | 28 | 0.360 |
Why?
|
| Muscular Diseases | 2 | 2025 | 12 | 0.350 |
Why?
|
| Mice | 10 | 2022 | 1244 | 0.290 |
Why?
|
| Glycogen | 2 | 2024 | 12 | 0.260 |
Why?
|
| Muscle Proteins | 2 | 2022 | 23 | 0.220 |
Why?
|
| Glucose | 2 | 2023 | 43 | 0.210 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 50 | 0.210 |
Why?
|
| Mutation | 3 | 2020 | 330 | 0.200 |
Why?
|
| Humans | 8 | 2025 | 23541 | 0.200 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 7 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 2 | 2020 | 12 | 0.190 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2022 | 16 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 47 | 0.190 |
Why?
|
| Phenotype | 2 | 2020 | 260 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2018 | 472 | 0.180 |
Why?
|
| Genotype | 1 | 2020 | 248 | 0.160 |
Why?
|
| Risk Factors | 1 | 2025 | 1997 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 110 | 0.150 |
Why?
|
| Myocardium | 2 | 2017 | 100 | 0.140 |
Why?
|
| Membrane Potentials | 3 | 2013 | 167 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 322 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2018 | 401 | 0.130 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 10 | 0.120 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 38 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 24 | 0.120 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 11 | 0.110 |
Why?
|
| Cell Membrane Permeability | 2 | 2011 | 51 | 0.110 |
Why?
|
| Hypothermia | 1 | 2013 | 5 | 0.100 |
Why?
|
| Adult | 3 | 2020 | 7168 | 0.100 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 5 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 81 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2012 | 5 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 165 | 0.100 |
Why?
|
| Rana pipiens | 1 | 2012 | 50 | 0.090 |
Why?
|
| Magnesium | 1 | 2012 | 35 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 176 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 305 | 0.090 |
Why?
|
| Algorithms | 1 | 2013 | 317 | 0.090 |
Why?
|
| Female | 2 | 2020 | 13239 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 61 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 22 | 0.050 |
Why?
|
| Male | 1 | 2018 | 12743 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 10 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 20 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 12 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 38 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 69 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cytosol | 2 | 2012 | 40 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2011 | 87 | 0.040 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 2 | 0.040 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 2 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 2 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 131 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 99 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 603 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2017 | 106 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 88 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 261 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 8 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 39 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 82 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 114 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2011 | 12 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 37 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 97 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 524 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7572 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 8134 | 0.020 |
Why?
|